Monoclonal antibody therapeutics for infectious diseases: Beyond normal human immunoglobulin

Antibody therapy is effective for treating infectious diseases. Due to the coronavirus disease 2019 (COVID-19) pandemic and the rise of drug-resistant bacteria, rapid development of neutralizing monoclonal antibodies (mAbs) to treat infectious diseases is urgently needed. Using a therapeutic human m...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsubo, Ryota, Yasui, Teruhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212443/
https://www.ncbi.nlm.nih.gov/pubmed/35738431
http://dx.doi.org/10.1016/j.pharmthera.2022.108233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212443/
https://www.ncbi.nlm.nih.gov/pubmed/35738431
http://dx.doi.org/10.1016/j.pharmthera.2022.108233

Ejemplares similares